Li S - Search Results

1

Germline HLA-B evolutionary divergence influences the efficacy of immune checkpoint blockade therapy in gastrointestinal cancer.

Lu Z, Chen H, Jiao X, Wang Y, Wu L, Sun H, Li S, Gong J, Li J, Zou J, Yang K, Hu Y, Mao B, Zhang L, Zhang X, Peng Z, Lu M, Wang Z, Zhang H, Shen L. Lu Z, et al. Among authors: li s, li j. Genome Med. 2021 Nov 3;13(1):175. doi: 10.1186/s13073-021-00997-6. Genome Med. 2021. PMID: 34732240 Free PMC article.

2

A novel oral camptothecin analog, gimatecan, exhibits superior antitumor efficacy than irinotecan toward esophageal squamous cell carcinoma in vitro and in vivo.

Zou J, Li S, Chen Z, Lu Z, Gao J, Zou J, Lin X, Li Y, Zhang C, Shen L. Zou J, et al. Among authors: li s, li y. Cell Death Dis. 2018 May 31;9(6):661. doi: 10.1038/s41419-018-0700-0. Cell Death Dis. 2018. PMID: 29855512 Free PMC article.

3

Serological Markers Associated With Response to Immune Checkpoint Blockade in Metastatic Gastrointestinal Tract Cancer.

Lu Z, Zou J, Hu Y, Li S, Zhou T, Gong J, Li J, Zhang X, Zhou J, Lu M, Wang X, Peng Z, Qi C, Li Y, Li J, Li Y, Zou J, Du X, Zhang H, Shen L. Lu Z, et al. Among authors: li s, li y, li j. JAMA Netw Open. 2019 Jul 3;2(7):e197621. doi: 10.1001/jamanetworkopen.2019.7621. JAMA Netw Open. 2019. PMID: 31339548 Free PMC article.

4

Baseline derived neutrophil-to-lymphocyte ratio as a prognostic biomarker for non-colorectal gastrointestinal cancer patients treated with immune checkpoint blockade.

Li S, Zou J, Liu C, Jiao X, Gong J, Li J, Wang Z, Lu M, Lu Z, Shen L. Li S, et al. Among authors: li j. Clin Immunol. 2020 Mar;212:108345. doi: 10.1016/j.clim.2020.108345. Epub 2020 Jan 15. Clin Immunol. 2020. PMID: 31953149 Free article.

5

Epigenetic therapy inhibits metastases by disrupting premetastatic niches.

Lu Z, Zou J, Li S, Topper MJ, Tao Y, Zhang H, Jiao X, Xie W, Kong X, Vaz M, Li H, Cai Y, Xia L, Huang P, Rodgers K, Lee B, Riemer JB, Day CP, Yen RC, Cui Y, Wang Y, Wang Y, Zhang W, Easwaran H, Hulbert A, Kim K, Juergens RA, Yang SC, Battafarano RJ, Bush EL, Broderick SR, Cattaneo SM, Brahmer JR, Rudin CM, Wrangle J, Mei Y, Kim YJ, Zhang B, Wang KK, Forde PM, Margolick JB, Nelkin BD, Zahnow CA, Pardoll DM, Housseau F, Baylin SB, Shen L, Brock MV. Lu Z, et al. Among authors: li s, li h. Nature. 2020 Mar;579(7798):284-290. doi: 10.1038/s41586-020-2054-x. Epub 2020 Feb 26. Nature. 2020. PMID: 32103175 Free PMC article.

6

Tumor copy-number alterations predict response to immune-checkpoint-blockade in gastrointestinal cancer.

Lu Z, Chen H, Li S, Gong J, Li J, Zou J, Wu L, Yu J, Han W, Sun H, Jiao X, Zhang X, Peng Z, Lu M, Wang Z, Zhang H, Shen L. Lu Z, et al. Among authors: li s, li j. J Immunother Cancer. 2020 Aug;8(2):e000374. doi: 10.1136/jitc-2019-000374. J Immunother Cancer. 2020. PMID: 32792358 Free PMC article.

7

Prediction of immune checkpoint inhibition with immune oncology-related gene expression in gastrointestinal cancer using a machine learning classifier.

Lu Z, Chen H, Jiao X, Zhou W, Han W, Li S, Liu C, Gong J, Li J, Zhang X, Wang X, Peng Z, Qi C, Wang Z, Li Y, Li J, Li Y, Brock M, Zhang H, Shen L. Lu Z, et al. Among authors: li s, li y, li j. J Immunother Cancer. 2020 Aug;8(2):e000631. doi: 10.1136/jitc-2020-000631. J Immunother Cancer. 2020. PMID: 32792359 Free PMC article.

8

Early change in peripheral CD4⁺ T cells associated with clinical outcomes of immunotherapy in gastrointestinal cancer.

Liu C, Wang Y, Li S, Jiao X, Zou J, Wang Z, Qi C, Zhang X, Li J, Lu Z, Shen L. Liu C, et al. Among authors: li s, li j. Immunotherapy. 2021 Jan;13(1):55-66. doi: 10.2217/imt-2020-0068. Epub 2020 Oct 22. Immunotherapy. 2021. PMID: 33086925

9

A genomic mutation signature predicts the clinical outcomes of immunotherapy and characterizes immunophenotypes in gastrointestinal cancer.

Jiao X, Wei X, Li S, Liu C, Chen H, Gong J, Li J, Zhang X, Wang X, Peng Z, Qi C, Wang Z, Wang Y, Wang Y, Zhuo N, Zhang H, Lu Z, Shen L. Jiao X, et al. Among authors: li s, li j. NPJ Precis Oncol. 2021 May 4;5(1):36. doi: 10.1038/s41698-021-00172-5. NPJ Precis Oncol. 2021. PMID: 33947957 Free PMC article.

10

PTCH1 mutation promotes antitumor immunity and the response to immune checkpoint inhibitors in colorectal cancer patients.

Wang Y, Chen H, Jiao X, Wu L, Yang Y, Zhang J, Wu L, Liu C, Zhuo N, Li S, Gong J, Li J, Zhang X, Wang X, Peng Z, Qi C, Wang Z, Li J, Li Y, Lu Z, Zhang H, Shen L. Wang Y, et al. Among authors: li s, li y, li j. Cancer Immunol Immunother. 2022 Jan;71(1):111-120. doi: 10.1007/s00262-021-02966-9. Epub 2021 May 24. Cancer Immunol Immunother. 2022. PMID: 34028566 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

98,329 results

Search Page

Filters